eMedicine Specialties > Obstetrics and Gynecology > General Gynecology

First-Trimester Pregnancy Loss: Follow-up

Author: Elizabeth E Puscheck, MD, Associate Professor, Department of Obstetrics and Gynecology, Wayne State University School of Medicine; In Vitro Fertilization Director, Medical Director, Gynecologic Ultrasound Director, Clinical Endocrine Laboratory Consultant, Department of Obstetrics and Gynecology, University Women's Care
Coauthor(s): Archana Pradhan, MD, MPH, Staff Physician, Department of Obstetrics and Gynecology, Nassau University Medical Center
Contributor Information and Disclosures

Updated: Jun 25, 2006

Follow-up

Further Inpatient Care

  • The follow-up should include monitoring hCG levels until the hCG levels are less than 5 mIU/mL. Patients do not need to remain in the hospital during this observation time period.

Further Outpatient Care

  • With a complete abortion, measure the hCG level weekly until it is less than 5 mIU/mL in situations in which the products of conception were not evaluated by a physician (eg, the products were flushed down the toilet).
  • If the expelled products of conception are evaluated by a physician and confirmed to be intact and truly products of conception (not a clot), performing any further follow-up tests is not necessary.
  • Providing reassurance and routine gynecologic care is recommended.
  • For ectopic pregnancies, the hCG levels should be monitored as noted above, particularly if medical therapy is performed. If surgical therapy is performed and it is a linear salpingostomy, then the hCG levels should be monitored until they are less than 5 mIU/mL. If a complete salpingectomy is performed and the pathology confirms the ectopic pregnancy, then one may forgo the follow-up for hCG levels.

Deterrence/Prevention

  • Contraceptive counseling is warranted. Patients should avoid intercourse or use contraception until the hCG levels have become negative. Patients may wish to continue contraception until they are emotionally ready to try again to become pregnant.

Complications

  • Complete abortions may be complicated by infection or accumulation of clot in the uterine cavity without expulsion due to uterine atony. Both of these complications are rare.
  • Occasionally, a decidual cast is passed and is mistaken for products of conception. In these cases, an ectopic pregnancy is likely.

Prognosis

  • The prognosis is excellent. After one complete abortion, no increased risk exists for another one. Patients need reassurance. Tender loving care is proven effective therapy in one randomized recurrent pregnancy loss trial.

Patient Education

  • The patient needs to hear that one miscarriage does not put her at increased risk for another miscarriage. Her next pregnancy is likely to last to term if she is young and has no other risk factors.
  • Advise the patient to return to the emergency department if any of the following symptoms occur:
    • Profuse vaginal bleeding
    • Severe pelvic pain
    • Temperature greater than 100°F
  • Patients may experience intermittent menstrual-like flow and cramps during the following week. The next menstrual period usually occurs in 4-5 weeks.
  • Patients may resume regular activities when able, but they should refrain from intercourse and douching for approximately 2 weeks.
  • For excellent patient education resources, visit eMedicine's Pregnancy and Reproduction Center. Also, see eMedicine's patient education articles Miscarriage, Abortion, Ectopic Pregnancy, and Dilation and Curettage (D&C).

Miscellaneous

Medicolegal Pitfalls

  • Failure to diagnose correctly may occur in this situation. A presumed completed abortion may be an ectopic pregnancy with passage of clot where the clot was thought to be tissue. Missing an ectopic pregnancy can be a life-threatening situation. Be careful. If uncertainty exists regarding whether the passed tissue is tissue or a clot, have a pathologist evaluate it prior to sending the patient out.
  • If a suction D&C is performed, then a known complication in a small percentage of cases is Asherman syndrome or intrauterine synechiae. This situation may cause amenorrhea, infertility, or miscarriage in these patients in the future. Be gentle with the sharp curettage after the suction, and, if there is difficulty, ultrasound guidance may be helpful. Do not forget that bleeding may be occurring due to DIC, which will not respond to a D&C but needs the missing factors replaced.
  • Perforation of the uterus may occur if a suction D&C is performed. Pregnant uteri are softer than the unpregnant state, and it is easier to perforate. Uterine perforation may occlude itself naturally because the uterus is a muscle that can undergo contraction and place its own pressure on the site until the bleeding stops. However, uncontrolled internal bleeding from a uterine perforation may require additional surgery, either a laparoscopy or laparotomy to control the bleeding. Occasionally, a hysterectomy may be the last resort to control the bleeding, which would eliminate the patient's ability to conceive in the future. Unrecognized uterine perforations may lead to significant internal bleeding that could be a life threat. Observe patients closely after a D&C and listen when patients complain of unusual symptoms (eg, shoulder pain, unexpectedly significant abdominal pain).
  • Misdiagnosis of an early intrauterine pregnancy for an ectopic pregnancy and administering methotrexate inappropriately may occur if the physician is not familiar with the laboratory and ultrasound department's discriminatory zone. Thinking about the patient's history and physical examination, differential diagnosis (including multiple gestations), the accuracy of the gestational age, the hCG level (and pattern of hCG levels if checked every 2 d), and ultrasonographic findings is very important to make an appropriate diagnosis. This is an area of rapidly growing malpractice in obstetrics and gynecology.
  • Misdiagnosis of an ectopic pregnancy as an incomplete or inevitable abortion can be a problem. In these cases, it is important to follow up on the pathology findings from the suction D&C. If one is uncertain, ask pathology to evaluate the specimen while one is still in the operating room and proceed to laparoscopy if no chorionic villi are found in the suction D&C specimen.
 


More on First-Trimester Pregnancy Loss

Overview: First-Trimester Pregnancy Loss
Differential Diagnoses & Workup: First-Trimester Pregnancy Loss
Treatment & Medication: First-Trimester Pregnancy Loss
Follow-up: First-Trimester Pregnancy Loss
References

References

  1. ACOG practice bulletin. Medical management of tubal pregnancy. Number 3, December 1998. Clinical management guidelines for obstetrician- gynecologists. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. Apr 1999;65(1):97-103. [Medline].

  2. Chipchase J, James D. Randomised trial of expectant versus surgical management of spontaneous miscarriage. Br J Obstet Gynaecol. Jul 1997;104(7):840-1. [Medline].

  3. Chung TK, Cheung LP, Sahota DS, et al. Spontaneous abortion: short-term complications following either conservative or surgical management. Aust N Z J Obstet Gynaecol. Feb 1998;38(1):61-4. [Medline].

  4. Creinin MD, Schwartz JL, Guido RS, Pymar HC. Early pregnancy failure--current management concepts. Obstet Gynecol Surv. Feb 2001;56(2):105-13. [Medline].

  5. Geyman JP, Oliver LM, Sullivan SD. Expectant, medical, or surgical treatment of spontaneous abortion in first trimester of pregnancy? A pooled quantitative literature evaluation. J Am Board Fam Pract. Jan-Feb 1999;12(1):55-64. [Medline].

  6. Herbst AL, Mishell DR, Stenchever MA, Droegemueller W, eds. Comprehensive Gynecology. St. Louis, Mo:. Mosby-Year Book;1992:445-453.

  7. Hurd WW, Whitfield RR, Randolph JF Jr, et al. Expectant management versus elective curettage for the treatment of spontaneous abortion. Fertil Steril. Oct 1997;68(4):601-6. [Medline].

  8. Jurkovic D, Ross JA, Nicolaides KH. Expectant management of missed miscarriage. Br J Obstet Gynaecol. Jun 1998;105(6):670-1. [Medline].

  9. Kalousek DK. Clinical significance of morphologic and genetic examination of spontaneously aborted embryos. Am J Reprod Immunol. Feb 1998;39(2):108-19. [Medline].

  10. Keith SC, London SN, Weitzman GA. Serial transvaginal ultrasound scans and beta-human chorionic gonadotropin levels in early singleton and multiple pregnancies. Fertil Steril. May 1993;59(5):1007-10. [Medline].

  11. Nielsen S, Hahlin M. Expectant management of first-trimester spontaneous abortion. Lancet. Jan 14 1995;345(8942):84-6. [Medline].

  12. Scroggins KM, Smucker WD, Krishen AE. Spontaneous pregnancy loss: evaluation, management, and follow-up counseling. Prim Care. Mar 2000;27(1):153-67. [Medline].

  13. Weeks A, Alia G, Blum J, et al. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstet Gynecol. Sep 2005;106(3):540-7.

  14. Zhang J, Gilles JM, Barnhart K, et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. Aug 25 2005;353(8):761-9.

Further Reading

Keywords

first-trimester pregnancy loss, miscarriage, spontaneous abortion, abortion, pregnancy loss, voluntary pregnancy termination, pregnancy termination, induced pregnancy termination, pregnancy complications, spontaneous complete abortion, ectopic pregnancy, incomplete abortion, inevitable abortion

Contributor Information and Disclosures

Author

Elizabeth E Puscheck, MD, Associate Professor, Department of Obstetrics and Gynecology, Wayne State University School of Medicine; In Vitro Fertilization Director, Medical Director, Gynecologic Ultrasound Director, Clinical Endocrine Laboratory Consultant, Department of Obstetrics and Gynecology, University Women's Care
Elizabeth E Puscheck, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Society for Reproductive Medicine, Association of Professors of Gynecology and Obstetrics, Endocrine Society, International Society for Clinical Densitometry, North American Menopause Society, Sigma Xi, Society for Assisted Reproductive Technologies, and Society of Reproductive Surgeons
Disclosure: Ferring Grant/research funds Other

Coauthor(s)

Archana Pradhan, MD, MPH, Staff Physician, Department of Obstetrics and Gynecology, Nassau University Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Suzanne R Trupin, MD, Clinical Professor of Obstetrics and Gynecology, University of Illinois College of Medicine-Champaign; CEO and Owner, Women's Health Practice; CEO and Owner, Hada Cosmetic Medicine and Midwest Surgical Center
Suzanne R Trupin, MD is a member of the following medical societies: American Association of Gynecologic Laparoscopists, American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, Association of Reproductive Health Professionals, International Society for Clinical Densitometry, and North American Menopause Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Richard S Legro, MD, Professor, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Pennsylvania State University College of Medicine; Consulting Staff, Milton S Hershey Medical Center
Richard S Legro, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine, Endocrine Society, Phi Beta Kappa, and Society of Reproductive Surgeons
Disclosure: Nothing to disclose.

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Assumption Community Hospital
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

Lee P Shulman, MD, Professor of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University; Chief, Division of Reproductive Genetics, Department of Obstetrics and Gynecology, Prentice Women's Hospital, Northwestern Memorial Hospital
Lee P Shulman, MD is a member of the following medical societies: American College of Medical Genetics, American College of Obstetricians and Gynecologists, American Medical Association, American Society for Reproductive Medicine, American Society of Human Genetics, Association of Reproductive Health Professionals, Central Association of Obstetricians and Gynecologists, Chicago Medical Society, Illinois State Medical Society, North American Society for Pediatric and Adolescent Gynecology, Phi Beta Kappa, Society for Gynecologic Investigation, Society for Maternal-Fetal Medicine, and Tennessee Medical Association
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
RELATED MEDSCAPE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.